Sudarshan Pharma Industries Ltd — Updates, 19-06-2025: Company Update

Sudarshan Pharma Industries has announced a board meeting that approved a proposal to raise funds up to ₹1500 Cr through various permissible modes. This may include public issue, preferential issue, qualified institutional placement, private placement, or a combination thereof, involving equity shares, foreign currency convertible bonds, fully or partly convertible debentures, non-convertible debentures with warrants, or other convertible securities. The fundraise may happen in one or more tranches in domestic and/or international markets, subject to necessary approvals. This move aims to support the company’s growth and financial strategy.